Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MET | P08581 | 4/20 | 0.42 |
| ▸ | CSF1R | P07333 | 3/20 | 0.36 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.35 |
| ▸ | MTOR | P42345 | 1/20 | 0.35 |
| ▸ | BCL6 | P41182 | 7/20 | 0.35 |
| ▸ | MAP4K3 | Q8IVH8 | 2/20 | 0.34 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.32 |
| ▸ | JAK2 | O60674 | 1/20 | 0.32 |
| ▸ | PDCD1LG2 | Q9BQ51 | 1/20 | 0.32 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.32 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.31 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL488396 | 1.00 | MET (0.42) | METCSF1RPIK3CAMTORBCL6 | |
| SCHEMBL488731 | 0.86 | KDM4E (0.40) | METCSF1RMTOR | |
| SCHEMBL30453950 | 0.86 | KDM4E (0.40) | METCSF1RMTOR | |
| SCHEMBL30453714 | 0.85 | MET (0.54) | METCSF1RMAP4K3 | |
| SCHEMBL10216276 | 0.85 | MET (0.54) | METCSF1RMAP4K3 | |
| SCHEMBL488137 | 0.85 | MET (0.54) | METCSF1RMAP4K3 | |
| SCHEMBL488176 | 0.85 | MET (0.52) | METPIK3CAMTORBCL6MAP4K3 | |
| SCHEMBL10215491 | 0.85 | MET (0.52) | METPIK3CAMTORBCL6MAP4K3 | |
| SCHEMBL30452564 | 0.85 | MET (0.52) | METPIK3CAMTORBCL6MAP4K3 | |
| SCHEMBL10216291 | 0.83 | MET (0.48) | METCSF1RMAP4K3PTPN11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113181362-B | Medicament for preventing and/or treating amyotrophic lateral sclerosis | 国立大学法人京都大学 | 2023-06-13 | — | — | CN | disclosed |